Some questions from Russian thread.
I’ve read the description of your conception and have a question. How much does pharmaceutical company need to spend to introduce your technology; what equipment and software needed?
I'll forward the question to our team, as I'm currently not sure of this. Give me a few day or 2 to get a clear answer on it.
I’ve opened the link for whitebook but it is not available at the moment. Do you have agreements with pharmaceutical companies producing medicine or at least maybe you work to some activates with them??
The paper has been updated, but they forgot the name format,
This is the correct link. Currently we have received clear indication from an European Pharmaceutical (~50B yearly turnover) that they are interested in our technology, but due to an NDA we can't openly discuss this. I have requested our CEO to give me the complete information, as I do not receive all the direct information if a company shows information.
Edit: Our CEO gave me the following: The cost of implementation lays into the Millions but it all depends on the length and size of the entire company chain. Do not forget, even if the costs are seemingly high, the market we are speaking about has over 1,3Tn turnover yearly. As example this is the top 10 company's:
![](https://ip.bitcointalk.org/?u=https%3A%2F%2Fi1.wp.com%2Figeahub.com%2Fwp-content%2Fuploads%2F2017%2F03%2Fcover-v6.jpg%3Fw%3D840%26ssl%3D1&t=663&c=OGx7NvOH5OQXhg)
Currently we are in talking position with 5 company's and 2 entire country's. We expect to be able to publish 1 or 2 in late Jan, but currently it is all under Non Disclosure Agreement.